BIOX
NASDAQ
AR
Bioceres Crop Solutions Corp. - Ordinary Shares
$0.54
▲ +$0.07
(+13.68%)
Vol 563K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$82.8M
ROE
-19.7%
Margin
-21.3%
D/E
99.92
Beta
0.51
52W
$1–$7
Wall Street Consensus
6 analysts · Apr 20260
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Earnings
Beat rate: 20.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.07 | $-0.08 | $-0.15 |
| Sep 2025 | $-0.07 | $-0.12 | $-0.05 |
| Jun 2025 | $0.08 | $-0.70 | $-0.78 |
| Mar 2025 | $-0.15 | $-0.02 | +$0.13 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Revenue | $98.9M | $59.6M | $74.4M | $77.4M | $73.7M |
| Net Income | $144K | -$1.3M | -$47.9M | -$7.3M | -$183.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -18.6% | -2.9% | -2.9% | -2.9% | -19.8% | -19.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -64.4% | 0.4% | -18.4% | -18.4% | -21.4% | -21.3% |
| Gross Margin | 33.6% | 42.3% | 39.1% | 39.1% | 41.1% | 41.1% |
| D/E Ratio | 104.21 | 88.60 | 88.60 | 88.60 | 99.96 | 99.92 |
| Current Ratio | 0.91 | 1.02 | 1.02 | 1.02 | 0.91 | 0.94 |
Key Ratios
ROA (TTM)
-7.2%
P/S (TTM)
0.32
P/B
1.1
EPS (TTM)
$-0.88
CF/Share
$0.64
Rev Growth 3Y
+0.5%
52W High
$7.44
52W Low
$1.20
$1.20
52-Week Range
$7.44
Financial Health
Free Cash Flow
$17.2M
Net Debt
$228.4M
Cash
$11.1M
Total Debt
$239.5M
As of Dec 31, 2025
How does BIOX compare to Chemicals peers?
Peer group: Micro-cap Chemicals (All) · 25 companies
BIOX valuation vs Chemicals peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Fair value
P/S ratio
0.3
▼
70%
below
peers
(1.1)
vs Peers
vs Industry
Undervalued
P/B ratio
1.1
▲
9%
above
peers
(1.0)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(1.9%)
vs Peers
vs Industry
Low yield
BIOX profitability vs Chemicals peers
ROE
-19.7%
▼
390%
below
peers
(-4.0%)
vs Peers
vs Industry
Weak
Net margin
-21.3%
▼
385%
below
peers
(-4.4%)
vs Peers
vs Industry
Weak
Gross margin
41.2%
▲
47%
above
peers
(28.0%)
vs Peers
vs Industry
Below avg
ROA
-7.2%
▼
418%
below
peers
(-1.4%)
vs Peers
vs Industry
Below avg
BIOX financial health vs Chemicals peers
D/E ratio
99.9
▲
121%
above
peers
(45.2)
vs Peers
vs Industry
High debt
Current ratio
0.9
▼
58%
below
peers
(2.2)
vs Peers
vs Industry
Low liquidity
Beta
0.5
▼
45%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
BIOX fundamentals radar
BIOX
Peer median
Industry
BIOX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BIOX vs peers: key metrics
Top Holders
Top 5: 17.88%Solel Partners LP
7.24%
$1.8M
Fourth Sail Capital LP
6.85%
$1.7M
Mirae Asset Global ETFs Hol…
1.54%
$382K
Long Focus Capital Manageme…
1.31%
$324K
Marshall Wace LLP
0.94%
$233K
As of Dec 31, 2025
Latest News
No related news yet